-
Can ACE inhibitors/ARB antihypertensive drugs prevent cardiotoxicity caused by chemotherapy in early breast cancer?
Time of Update: 2022-10-19
A meta-analysis published in the journal Transl Cancer Res evaluated the effect of ACE inhibitors/ARBs on cardiotoxicity induced by anthracycline chemotherapy with or without trastuzumab in patients with early-stage breast cancer。 ACEI and ARB have a definite antihypertensive effect, especially in patients with heart failure, myocardial infarction, diabetes, and chronic kidney disease, and there is sufficient evidence to improve prognosis.
-
BMC Cancer: Comparison of survival outcomes after radical chemoradiotherapy in patients
Time of Update: 2022-04-23
Recently, a team from the Southern Hospital of Southern Medical University published a study in the journal BMC Cancer, mainly comparing the outcomes of patients with cervical squamous cell carcinoma (SCC) and adenocarcinoma/adenosquamous carcinoma (AC/ASC) after radiotherapy and chemotherapy.
-
The American Cancer Society (ACS) authoritatively released: Nearly half of cancer occurrences and deaths can be prevented!
Time of Update: 2021-06-01
BJ Haem: Family aggregation of early-onset hematological malignancies CLIN CANCER RES: Afatinib VS Afatinib + Cetuximab as the first-line treatment option for EGFR-mutant non-small cell lung cancer (NSCLC) patients (IFCT-1503 ACE-Lung) Phase II randomized trial 01 First-line advanced NSCLC New treatment plan!
-
Ace breast cancer products actively reduce prices by more than 50%, Pfizer in China's tumor market how to do?
Time of Update: 2021-02-11
Under the goal of "bringing breakthrough innovation to change patients' lives" and patient-centered win-win development strategy, how to accelerate product introduction, how to lay out and match different market strategies and access methods for different products, the transformation of Pfizer needs to continue to prove its market dominance and competitiveness.
-
ACS Nano: "Sprinkle urine photo"! AI diagnoses prostate cancer with latest breakthrough in just 20 minutes, nearly 100% accuracy
Time of Update: 2021-02-04
In this latest study, the Korea Institute of Science and Technology announced that a team of researchers led by Dr. Kwan Hyi Lee of the Center for Biomass Research and Professor In Gab Jeong of Asan Medical Center has developed a technology to diagnose prostate cancer from urine in just 20 minutes with nearly 100% accuracy by introducing AI analysis into ultra-sensitive biosensors based on electrical signals.
-
ACS Nano: new technology for early diagnosis of cancer
Time of Update: 2020-02-12
February 12, 2020 / BIOON / -- a group of researchers from the Institute of materials science, Kaunas University of Technology (ktu) and colleagues in Japan have come up with a method to force more th
-
ACS cent SCI: a new study reveals the mechanism of anti-cancer stem cells by sarithromycin
Time of Update: 2018-07-24
July 24, 2018 / BIOON / - a research team from Lund University in Sweden has developed a new fluorescent molecule that can inhibit tumor stem cells By capturing the fluorescence information when the m
-
ACS Nano: Li Yaping's team from Shanghai Institute of Medicine found that light activated
Time of Update: 2018-03-28
Three negative breast cancer (TNBC) has high heterogeneity There are a large number of mesenchymal cells with high metastatic capacity in its core and rapidly proliferating cells in its periphery Ther
-
ACS Omega: Chinese ink can effectively "kill" cancer cells
Time of Update: 2017-09-28
Ink, for the Chinese people, will not be strange For hundreds of years, Chinese calligraphers have created numerous paintings and calligraphy works with plant ink Recently, the research team of Shangh